Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hamilton

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Nature Cancer|June 10, 2021
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemiaJeevisha Bajaj, Michael Hamilton, Yutaka Shima, et al.
Frontiers in Veterinary Science|May 26, 2025
Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)Mike Farrell, Felix W A Waibel, Ines Carrera, et al.
Nature Communications|January 18, 2023
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinomaL Paige Ferguson, Jovylyn Gatchalian, Matthew L McDermott, et al.
Cancer Cell|October 6, 2023
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancerNirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2012
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitusJeffrey A Pfefferkorn, Meihua Tu, Kevin J Filipski, et al.
Cell|April 9, 2019
A Multiscale Map of the Stem Cell State in Pancreatic AdenocarcinomaNikki K Lytle, L Paige Ferguson, Nirakar Rajbhandari, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Nature Cancer|June 10, 2021
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemiaJeevisha Bajaj, Michael Hamilton, Yutaka Shima, et al.
Frontiers in Veterinary Science|May 26, 2025
Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)Mike Farrell, Felix W A Waibel, Ines Carrera, et al.
Nature Communications|January 18, 2023
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinomaL Paige Ferguson, Jovylyn Gatchalian, Matthew L McDermott, et al.
Cancer Cell|October 6, 2023
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancerNirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2012
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitusJeffrey A Pfefferkorn, Meihua Tu, Kevin J Filipski, et al.
Cell|April 9, 2019
A Multiscale Map of the Stem Cell State in Pancreatic AdenocarcinomaNikki K Lytle, L Paige Ferguson, Nirakar Rajbhandari, et al.
Pageof 7